Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: A LIFE substudy

Journal of Human Hypertension

Volumn 18, Issue 6, 2004, Pages 445-452

  Olsen, M H ^a   Wachtell, K ^a,b   Meyer, C ^c   Hove, J D ^c   Palmieri, V ^b   Dige Petersen, H ^a   Rokkedal, J ^a   Hesse, B ^c   Ibsen, H ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

Carotid arteries; Endothelium; Hypertrophy

Indexed keywords

ATENOLOL; DIPYRIDAMOLE; GLYCERYL TRINITRATE; LOSARTAN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY DILATATION; ARTERY INTIMA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE BLOOD FLOW; HEART RATE; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; MYOGRAPHY; PLETHYSMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

AGED; BRACHIAL ARTERY; CAROTID ARTERIES; CORONARY CIRCULATION; FEMALE; HEART; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; TUNICA INTIMA; TUNICA MEDIA; VASCULAR RESISTANCE;

EID: 2942711717     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001716     Document Type: Article

References (38)

1. Liao Y et al. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997; 29: 641-647.
2. Vogt M, Motz W, Scheler S, Strauer BE. Disorders of coronary microcirculation and arrhythmias in systemic arterial hypertension. Am J Cardiol 1990; 65: 45G-50G.
3. Motz W, Scheler S, Schwartzkopff B, Strauer BE. Evaluation of cardiac damage in hypertension. J Cardiovasc Risk 1995; 2: 16-26.
4. Kozakova M et al. Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. Hypertension 1997; 29: 551-559.
5. Roman MJ et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909-1918.
6. Heagerty AM et al. Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension 1993; 21: 391-397.
7. Shore AC, Tooke JE. Microvascular function in human essential hypertension. J Hypertens 1994; 12: 717-728.
8. Li J et al. Non-invasive detection of endothelial dysfunction in patients with essential hypertension. Int J Cardiol 1997; 61: 165-169.
9. Panza JA, Quyyumi AA, Brush Jr JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27.
10. Falloon BJ, Heagerty AM. In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension 1994; 24: 16-23.
11. Lekakis JP et al. Peripheral vascular endothelial dysfunction in patients with angina pectoris and normal coronary arteriograms. J Am Coll Cardiol 1998; 31: 541-546.
12. Sax FL, Cannon III RO, Hanson C, Epstein SE. Impaired forearm vasodilator reserve in patients with microvascular angina. Evidence of a generalized disorder of vascular function? N Engl J Med 1987; 317: 1366-1370.
13. Leschke M et al. Reduced peripheral and coronary vasomotion in systemic hypertension. Eur Heart J 1992; 13 (Suppl D): 96-99.
14. Olsen MH et al. Relative influence of insulin resistance versus blood pressure on vascular changes in long-standing hypertension. ICARUS, a LIFE sub study. Insulin Carotids US Scandinavia. J Hypertens 2000; 18: 75-81.
15. Dahlof B et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension 1998; 32: 989-997.
16. WHO. WHO Technical Reports Series 727, 1985, p. 9.
17. Howard G et al, Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993; 24: 1297-1304.
18. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62: 347-504.
19. Cooper KE, Edholm OG, Mottram RF. The blood flow in skin and muscle of the human forearm. J Physiol 1955; 128: 258-267.
20. Utriainen T, Malmstrom R, Makimattila S, Yki-Jarvinen H. Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia 1995; 38: 555-564.
21. Palmieri V et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective randomized study evaluating regression of ventricular enlargement. J Am Coll Cardiol 1999; 34: 1625-1632.
22. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19-26.
23. Imai Y et al, The accuracy and performance of the A&D TM 2421, a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the Korotkoff sound technique. Am J Hypertens 1992; 5: 719-726.
24. Conway J, Coats A. Value of ambulatory blood pressure monitoring in clinical pharmacology. J Hypertens Suppl 1989; 7: S29-S32.
25. 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation 1992; 86: 1004-1017.
26. Rossen JD, Simonetti I, Marcus ML, Winniford MD. Coronary dilation with standard dose dipyridamole and dipyridamole combined with haudgrip. Circulation 1989; 79: 566-572.
27. Wilson RF et al. Effects of adenosine on human coronary arterial circulation. Circulation 1990; 82: 1595-1606.
28. Czernin J et al. Effects of modified pharmacologic stress approaches on hyperemic myocardial blood flow. J Nucl Med 1995; 36: 575-580.
29. Chan SY et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 1992; 20: 979-985.
30. Joannides R et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314-1319.
31. Iversen HK et al. Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate. Eur J Clin Pharmacol 1992; 42: 31-35.
32. Olsen MH et al. Vasodilatory capacity and vascular structure in long-standing hypertension: a LIFE sub-study. Losartan Intervention For Endpoint-Reduction in Hypertension. Am J Hypertension 2002; 15: 398-404.
33. Tadaoka S et al. Effect of left ventricular hypertrophy secondary to systemic hypertension on left coronary artery flow dynamics. Cardiovasc Res 1991; 25: 955-964.
34. Vogt M, Motz W, Strauer BE. Coronary haemodynamics in hypertensive heart disease. Eur Heart J 1992; 13 (Suppl D): 44-49.
35. Pedrinelli R et al. Myocardial and forearm blood flow reserve in mild-moderate essential hypertensive patients. J Hypertens 1997; 15: 667-673.
36. Buus NH et al. Reduced vasodilator capacity in syndrome X related to structure and function of resistance arteries. Am J Cardiol 1999; 83: 149-154.
37. Anderson TJ et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-1241.
38. Pitkanen OP et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes 1998; 47: 248-254.